Prolonged-Release Potassium Chloride Generics Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg)

Reference Brands: Klor-Con®, K-Dur®, K-Tab®, Micro-K® (US), KCl Retard®, Kaleorid®, Kalium-Retard®, Slow-K® (EU)

Category: Nephrology

Prolonged-release Potassium Chloride Generics is available in Tablet and strengths such as 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Prolonged-release Potassium Chloride Generics is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Prolonged-release Potassium Chloride Generics can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Prolonged-release Potassium Chloride is a vital electrolyte supplement used to treat and prevent hypokalemia in patients with chronic kidney disease (CKD), heart conditions, or those on diuretic therapy. Designed for steady potassium release, it helps maintain optimal serum potassium levels, reducing the risk of cardiac arrhythmias and muscle dysfunction. Widely prescribed in both the US and EU, it plays a crucial role in nephrology and cardiology. Ideal for B2B pharmaceutical supply, it is available in various strengths to meet diverse patient needs. Prolonged-release Potassium Chloride supports safe, effective potassium repletion in renal and electrolyte management protocols.